Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia

Blood

Volumn 94, Issue 6, 1999, Pages 1840-1847

  Damle, Rajendra N ^b   Wasil, Tarun ^b   Fais, Franco ^b   Ghiotto, Fabio ^b   Valetto, Angelo ^b   Allen, Steven L ^b   Buchbinder, Aby ^b   Budman, Daniel ^b   Dittmar, Klaus ^b   Kolitz, Jonathan ^b   Lichtman, Stuart M ^b   Schulman, Philip ^b   Vinciguerra, Vincent P ^b   Rai, Kanti R ^b   Ferrarini, Manlio ^b   Chiorazzi, Nicholas ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; FLUDARABINE; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOPHENOTYPING; MALE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 0033567968     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.6.1840.418k06_1840_1847     Document Type: Article

References (42)

1. Rai K, Patel D: Chronic lymphocytic leukemia, in Hoffman R, Benz E, Shattil S, Furie B, Cohen H, Silberstein L (eds): Hematology: Basic Principles and Practice (ed 2). New York, NY, Churchill Livingstone, 1995, p 1308
2. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1998. CA Cancer J Clin 48:6, 1998
3. Ries L, Miller B, Hankey B, et al: SEER cancer statistics review 1973-1991: Tables and Graphs. NIH Publication No. 94-2789. Bethesda, MD, National Cancer Institute, National Institutes of Health, 1994
4. Rai KR: Chronic lymphocytic leukemia in the elderly population. Clin Geriatr Med 13:245, 1997
5. Catovsky D, Fooks J, Richards S: Prognostic factors in chronic lymphocytic leukaemia: The importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults. Br J Haematol 72:141, 1989
6. Mandelli F, De Rossi G, Mancini P, Alberti A, Cajozzo A, Grignani F, Leoni P, Liso V, Martelli M, Neri A, Resegotti L, Torlontano G: Prognosis in chronic lymphocytic leukemia: A retrospective multicentric study from the GIMEMA group. J Clin Oncol 5:398, 1987
7. Zwiebel JA, Cheson BD: Chronic lymphocytic leukemia: Staging and prognostic factors. Semin Oncol 25:42, 1998
8. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Paternack BS: Clinical staging of chronic lymphocytic leukemia. Blood 46:219, 1975
9. Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, Vaugier G, Potron G, Colona P, Oberling F, Thomas M, Tchernia G, Jacquillat C, Boivin P, Lesty C, Duault MT, Monconduit M, Belabbes S, Gremy F: A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48:198, 1981
10. Rai K: A critical analysis of staging in CLL, in Gail R, Rai K (eds): Chronic Lymphocytic Leukemia. Recent Progress and Future Directions. New York, NY, Liss, 1987, p 253
11. Montserrat E, Sanchez-Bisono J, Vinolas N, Rozman C: Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance. Br J Haematol 62:567, 1986
12. Di Giovanni S, Valentini G, Carducci P, Giallonardo P: Beta-2-microglobulin is a reliable tumor marker in chronic lymphocytic leukemia. Acta Haematol 81:181, 1989
13. Keating MJ, Lerner S, Kantarjian H, Freireich EJ, O'Brien S: The serum β2-microglobulin level is more powerful than stage in predicting response and survival in chronic lymphocytic leukemia. Blood 86:606A, 1995 (abstr)
14. Sarfati M, Chevret S, Chastang C, Biron G, Stryckmans P, Delespesse G, Binet JL, Merle-Beral H, Bron D: Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. Blood 88:4259, 1996
15. Kallander CF, Simonsson B, Hagberg H, Gronowitz JS: Serum deoxythymidine kinase gives prognostic information in chronic lymphocytic leukemia. Cancer 54:2450, 1984
16. Hallek M. Langenmayer I, Nerl C, Knauf W, Dietzfelbinger H, Adorf D, Ostwald M, Busch R, Kuhn-Hallek I, Thiel E, Emmerich B: Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia. Blood 93:1732, 1999
17. Rozman C, Montserrat E, Rodriguez-Fernandez JM, Ayats R, Vallespi T, Parody R, Rios A, Prados D, Morey M, Gomis F, Alcala A, Gutierrez M, Maldonado J, Gonzalez C, Giralt M, Hernandez-Nieto L, Cabrera A, Fernandez-Ranada JM: Bone marrow histologic pattern -the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. Blood 64:642, 1984
18. Juliusson G, Oscier DG, Fitchett M, Ross FM, Stockdill G, Mackie MJ, Parker AC, Castoldi GL, Guneo A, Knuutila S, Elonen E, Gahrton G: Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 323:720, 1990
19. Caligaris-Cappio F, Gobbi M, Bofill M, Janossy G: Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J Exp Med 155:623, 1982
20. Schroeder HW Jr, Dighiero G: The pathogenesis of chronic lymphocytic leukemia: Analysis of the antibody repertoire. Immunol Today 15:288, 1994
21. Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen SL, Schulman P, Vinciguerra VP, Rai K, Rassenti LZ, Kipps TJ, Dighiero G, Schroeder HW, Ferrarini M, Chiorazzi N: Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 102:1515, 1998
22. Clark EA, Lane PJ: Regulation of human B-cell activation and adhesion. Annu Rev Immunol 9:97, 1991
23. Pascual V, Liu YJ, Magalski A, de Bouteiller O, Banchereau J, Capra JD: Analysis of somatic mutation in five B cell subsets of human tonsil. J Exp Med 180:329, 1994
24. Hashimoto S, Dono M, Wakai M, Allen SL, Lichtman SM, Schulman P, Vinciguerra VP, Ferrarini M, Silver J, Chiorazzi N: Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. J Exp Med 181:1507, 1995
25. Fais F, Sellars B, Ghiotto F, Van XJ, Dono M, Allen SL, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Schuster M, Vinciguerra VP, Rai K, Stevenson FK, Gregersen PK, Ferrarini M, Chiorazzi N: Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells. J Clin Invest 98:1659, 1996
26. Oscier DG, Thompsett A, Zhu D, Stevenson FK: Differential rates of somatic hypermutation in V(H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. Blood 89:4153, 1997
27. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK; Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94:1848, 1999
28. Klein U, Rajewsky K, Kuppers R: Human immunoglobulin M + IgD + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells, J Exp Med 188:1679, 1998
29. Paramithiotis E, Cooper MD: Memory B lymphocytes migrate to bone marrow in humans. Proc Natl Acad Sci USA 94:208, 1997
30. Arpin C, de Bouteiller O, Razanajaona D, Fugier-Vivier I, Briere F, Banchereau J, Lebecque S, Liu YJ: The normal counterpart of IgD myeloma cells in germinal center displays extensively mutated IgVH gene, Cmu-Cdelta switch, and lambda light chain expression. J Exp Med 187:1169, 1998
31. Agematsu K, Kobata T, Sugita K, Freeman GJ, Beckmann MP, Schlossman SF, Morimoto C: Role of CD27 in T cell immune response. Analysis by recombinant soluble CD27. J Immunol 153:1421, 1994
32. Tangye SG, Liu YJ, Aversa G, Phillips JH, de Vries JE: Identification of functional human splenic memory B cells by expression of CD148 and CD27. J Exp Med 188:1691, 1998
33. Ranheim EA, Cantwell MJ, Kipps TJ: Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells. Blood 85:3556, 1995
34. Trentin L, Zambello R, Sancetta R, Facco M, Cerutti A, Perin A, Siviero M, Basso U, Bortolin M, Adami F, Agostini C, Semenzato G: B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules. Cancer Res 57:4940, 1997
35. Kumagai M, Coustan-Smith E, Murray DJ, Silvennoinen O, Murti KG, Evans WE, Malavasi F, Campana D: Ligation of CD38 suppresses human B lymphopoiesis. J Exp Med 181:1101, 1995
36. Johnson TA, Rassenti LZ, Kipps TJ: Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol 158:235, 1997
37. Zupo S, Rugari E, Dono M, Taborelli G, Malavasi F, Ferrarini M: CD38 signaling by agonistic monoclonal antibody prevents apoptosis of human germinal center B cells. Eur J Immunol 24:1218, 1994
38. Funaro A, Morra M, Calosso L, Zini MG, Ausiello CM, Malavasi F: Role of the human CD38 molecule in B cell activation and proliferation. Tissue Antigens 49:7, 1997
39. Zupo S, Isnardi L, Megna M, Massara R, Malavasi F, Dono M, Cosulich E, Ferrarini M: CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis. Blood 88:1365, 1996
40. Koduru PRK, Lichtman SM, Smilari TF, Sun T, Goh JC, Karp L, Hall W, Hashimoto S, Chiorazzi N, Broome JD: Serial phenotypic, cytogenetic, and molecular genetic studies in Richter's syndrome: Demonstration of lymphoma development from the chronic lymphocytic leukemia cells. Br J Haematol 85:613, 1993
41. Cherepakhin V, Baird SM, Meisenholder GW, Kipps TJ: Common clonal origin of chronic lymphocytic leukemia and high-grade lymphoma of Richter's syndrome. Blood 82:3141, 1993
42. Newcomb EW, El Rouby S, Thomas A: A unique spectrum of p53 mutations in B cell chronic lymphocytic leukemia distinct from that of other lymphoid malignancies. Mol Carcinog 14:227, 1995